In two years following the launch of the pharmaceutical plant in late August 2015, VERTEX, a pharmaceutical company, manufactured more than 100 million packages of drugs at this new site, which in monetary terms amounts to more than 8.5 billion rubles, excluding VAT, in the delivery prices.
In terms of manufactured items, this includes about 1.8 billion tablets, and 180 million capsules; in terms of packages, about 7 million for ointments, more than 6.3 million for gels, and 4.7 million for creams; as well as the medicinal products in other dosage forms.
The products of VERTEX are available in more than 50,000 pharmacies in about 80 subjects of the Russian Federation, as well as in Kazakhstan and Belarus. In addition, VERTEX supplies the drugs for public procurement segment.
“The choice of consumers is influenced by the high standards of drugs manufacturing and their affordable price. As a result, consumes trust in Russian-made medicines is growing and their sales are growing too.” said Georgy Pobelyansky, the General Director of VERTEX.
Since the opening of the plant, the company began to manufacture at this site about 20 new generic and branded medicinal products to be used in cardiology, pulmonology, dermatology, neurology, and other areas of medicine. In two years, the company received 11 out of 18 company’s patents. The new equipment of leading manufacturers is regularly purchased and certified for laboratories of the quality control department, including the microbiological area of more than 300 sq. m.